AARTIDRUGS Quarterly Results, Profit & Loss, Balance Sheet (AARTIDRUGS)

AARTIDRUGS quarterly results and annual financials: sales, operating profit, OPM, net profit, EPS, balance sheet, cash flow and ratios like ROCE, with YoY and QoQ growth.

  • AARTIDRUGS Financials
  • AARTIDRUGS Shareholding Pattern
  • AARTIDRUGS Earnings Documents
  • AARTIDRUGS Announcements
  • AARTIDRUGS Corporate Actions
  • AARTIDRUGS Bulk, Block & Insider Deals
  • AARTIDRUGS Delivery Data
  • AARTIDRUGS Earnings Concalls
  • Market Timeline
  • Concall Monitor
  • Company Research
  • Earnings Monitor
  • Upcoming Results
  • Sector Monitor
  • Sector Performance
  • Bulk & Block Deals
  • Delivery Data
  • FII & DII Activity
  • Market Indices
  • Plans & Pricing

Aarti Drugs Ltd (AARTIDRUGS) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow

Aarti Drugs Ltd reported sales of ₹826 Cr, operating profit of ₹135 Cr (OPM 16%) and net profit of ₹83 Cr for the quarter ended Sep 2026. Figures in ₹ crore, consolidated where available.

AARTIDRUGS quarterly results (₹ Cr)
MetricDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Sales557677591653602720703826
YoY Sales growth-8969861927
Expenses495583516569547624605691
Operating Profit62937484559698135
OPM11%14%13%13%9%13%14%16%
Other Income1220011-13
Interest999898910
Depreciation1415151618181819
Profit before tax51715160297069109
Tax27%12%-6%25%-40%21%28%24%
Net Profit3763544541555083
EPS in Rs4.066.895.914.964.446.055.59.09
AARTIDRUGS profit & loss, annual (₹ Cr)
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales2,4892,7162,5292,3872,5652,851
Sales growth159-7-6715
Expenses2,1562,4072,2082,0972,2542,467
Operating Profit333309321290312384
OPM13%11%13%12%12%13%
Other Income11241623
Interest243738393636
Depreciation505051566773
Profit before tax270224236212211278
Tax24%26%27%21%8%-
Net Profit205166172168195229
EPS in Rs22.1417.9618.6518.4221.3625.08
Dividend Payout5%6%5%5%9%-
AARTIDRUGS balance sheet (₹ Cr)
MetricMar 2024Mar 2025Sep 2025Mar 2026Sep 2026
Equity Capital9291919191
Reserves1,1901,2781,3771,4581,590
Borrowings564615573577620
Other Liabilities587591570690753
Total Liabilities2,4322,5752,6122,8153,054
Fixed Assets8118661,0781,0861,113
CWIP261330179214236
Investments2022232728
Other Assets1,3401,3561,3321,4881,677
Total Assets2,4322,5752,6122,8153,054
AARTIDRUGS cash flows (₹ Cr)
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity70133359245254
Cash from Investing Activity-150-164-224-165-173
Cash from Financing Activity9217-136-82-77
Net Cash Flow13-14-1-23
Free Cash Flow-82-311336780
CFO/OP46%62%131%103%81%
CFO/EBITDAShare of operating profit converting into cash: CFO (before tax) / Operating Profit466213110380
AARTIDRUGS ratios
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days110116102115118
Inventory Days115101107114112
Days Payable1039494100109
Cash Conversion Cycle123123115129121
Working Capital Days6372747676
ROCE21%15%15%13%12%
  • AARTIDRUGS Shareholding Pattern
  • AARTIDRUGS Earnings Concalls
  • AARTIDRUGS Growth Catalysts
  • AARTIDRUGS Corporate Actions
  • AARTIDRUGS Announcements
  • AARTIDRUGS Results & Documents
  • AARTIDRUGS Bulk & Block Deals
  • AARTIDRUGS Delivery Data